The end of the pandemic could bring new restrictions on how practitioners can use telemedicine to prescribe controlled medications, including for opioid-use disorder and ADHD.
You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.
